| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 3.78e-08 | 3 | 68 | 3 | GO:0008389 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.03e-05 | 262 | 68 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 7.26e-05 | 24 | 68 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | DNA-directed DNA polymerase activity | 8.23e-05 | 25 | 68 | 3 | GO:0003887 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.04e-04 | 27 | 68 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 2.10e-04 | 34 | 68 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 2.29e-04 | 35 | 68 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.93e-04 | 38 | 68 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | preribosome binding | 3.16e-04 | 8 | 68 | 2 | GO:1990275 | |
| GeneOntologyMolecularFunction | 5'-deoxyribose-5-phosphate lyase activity | 3.16e-04 | 8 | 68 | 2 | GO:0051575 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 6.22e-04 | 49 | 68 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 8.70e-04 | 13 | 68 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 9.28e-04 | 127 | 68 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.11e-03 | 614 | 68 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 1.52e-03 | 645 | 68 | 8 | GO:0140640 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.69e-03 | 18 | 68 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.48e-03 | 166 | 68 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | LRR domain binding | 2.53e-03 | 22 | 68 | 2 | GO:0030275 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 2.76e-03 | 82 | 68 | 3 | GO:1990756 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.87e-03 | 441 | 68 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 4.18e-03 | 95 | 68 | 3 | GO:0140767 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 4.33e-03 | 194 | 68 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.99e-03 | 31 | 68 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.64e-03 | 33 | 68 | 2 | GO:0005217 | |
| GeneOntologyBiologicalProcess | maturation of LSU-rRNA | 1.30e-06 | 25 | 68 | 4 | GO:0000470 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 4.05e-06 | 10 | 68 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 4.05e-06 | 10 | 68 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | ribosomal large subunit biogenesis | 4.23e-06 | 73 | 68 | 5 | GO:0042273 | |
| GeneOntologyBiologicalProcess | negative regulation of negative chemotaxis | 1.07e-05 | 2 | 68 | 2 | GO:0050925 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 5.05e-05 | 22 | 68 | 3 | GO:0019373 | |
| GeneOntologyBiologicalProcess | regulation of negative chemotaxis | 6.40e-05 | 4 | 68 | 2 | GO:0050923 | |
| GeneOntologyBiologicalProcess | DNA replication | 7.45e-05 | 312 | 68 | 7 | GO:0006260 | |
| GeneOntologyBiologicalProcess | rRNA processing | 1.11e-04 | 230 | 68 | 6 | GO:0006364 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA replication | 1.18e-04 | 29 | 68 | 3 | GO:0008156 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | GTPBP4 SMARCA5 WAPL POLA1 NVL SPIRE1 POLL TAF2 DOT1L POLQ RAD17 MPG | 1.94e-04 | 1081 | 68 | 12 | GO:0006259 |
| GeneOntologyBiologicalProcess | negative regulation of mammary gland epithelial cell proliferation | 2.23e-04 | 7 | 68 | 2 | GO:0033600 | |
| GeneOntologyBiologicalProcess | axon midline choice point recognition | 2.23e-04 | 7 | 68 | 2 | GO:0016199 | |
| GeneOntologyBiologicalProcess | DNA repair | 2.66e-04 | 648 | 68 | 9 | GO:0006281 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 2.88e-04 | 39 | 68 | 3 | GO:0003180 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 2.91e-04 | 275 | 68 | 6 | GO:0016072 | |
| GeneOntologyBiologicalProcess | heart induction | 2.96e-04 | 8 | 68 | 2 | GO:0003129 | |
| GeneOntologyBiologicalProcess | positive regulation of animal organ morphogenesis | 3.34e-04 | 41 | 68 | 3 | GO:0110110 | |
| GeneOntologyBiologicalProcess | regulation of heart morphogenesis | 3.80e-04 | 9 | 68 | 2 | GO:2000826 | |
| GeneOntologyBiologicalProcess | axon choice point recognition | 3.80e-04 | 9 | 68 | 2 | GO:0016198 | |
| GeneOntologyBiologicalProcess | aortic valve development | 4.70e-04 | 46 | 68 | 3 | GO:0003176 | |
| GeneOntologyBiologicalProcess | base-excision repair | 4.70e-04 | 46 | 68 | 3 | GO:0006284 | |
| GeneOntologyBiologicalProcess | polar body extrusion after meiotic divisions | 4.74e-04 | 10 | 68 | 2 | GO:0040038 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 5.20e-04 | 564 | 68 | 8 | GO:0051052 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 5.78e-04 | 11 | 68 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 6.01e-04 | 50 | 68 | 3 | GO:1905314 | |
| MousePheno | abnormal spinal cord lateral column morphology | 1.63e-05 | 2 | 57 | 2 | MP:0009678 | |
| MousePheno | decreased intestinal cholesterol absorption | 4.20e-05 | 17 | 57 | 3 | MP:0002647 | |
| MousePheno | abnormal intestinal cholesterol absorption | 5.95e-05 | 19 | 57 | 3 | MP:0002645 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 1.68e-07 | 4 | 66 | 3 | IPR008067 | |
| Domain | AUTS2 | 3.68e-05 | 3 | 66 | 2 | IPR023246 | |
| Domain | Cyt_P450_E_grp-I | 5.38e-04 | 45 | 66 | 3 | IPR002401 | |
| Domain | ITAM_1 | 5.43e-04 | 10 | 66 | 2 | PS51055 | |
| Domain | Phos_immunorcpt_sig_ITAM | 5.43e-04 | 10 | 66 | 2 | IPR003110 | |
| Domain | Cyt_P450_CS | 8.70e-04 | 53 | 66 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.08e-03 | 57 | 66 | 3 | PS00086 | |
| Domain | - | 1.13e-03 | 58 | 66 | 3 | 1.10.630.10 | |
| Domain | p450 | 1.13e-03 | 58 | 66 | 3 | PF00067 | |
| Domain | Cyt_P450 | 1.25e-03 | 60 | 66 | 3 | IPR001128 | |
| Domain | PRAME_family | 2.02e-03 | 19 | 66 | 2 | IPR026271 | |
| Domain | AAA | 6.41e-03 | 34 | 66 | 2 | PS00674 | |
| Domain | Glyco_hydro_catalytic_dom | 7.97e-03 | 38 | 66 | 2 | IPR013781 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 6.00e-06 | 11 | 48 | 3 | M27130 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 7.98e-06 | 12 | 48 | 3 | MM14847 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.92e-05 | 18 | 48 | 3 | MM14841 | |
| Pathway | REACTOME_XENOBIOTICS | 6.25e-05 | 23 | 48 | 3 | M5372 | |
| Pathway | REACTOME_XENOBIOTICS | 8.08e-05 | 25 | 48 | 3 | MM14846 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS | 1.13e-04 | 5 | 48 | 2 | M47808 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 5.02e-04 | 10 | 48 | 2 | M27348 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 6.88e-04 | 51 | 48 | 3 | M17726 | |
| Pubmed | 1.85e-09 | 106 | 69 | 7 | 12429849 | ||
| Pubmed | GTPBP4 URB1 SMARCA5 UTP18 HYOU1 POLA1 NVL MAK16 RBM28 NOP2 ZMYM3 RAI1 | 5.77e-09 | 653 | 69 | 12 | 22586326 | |
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 7.47e-09 | 3 | 69 | 3 | 31645370 | |
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 3346244 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 2733794 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 8297477 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 8188299 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 8484736 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 8250953 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 2703500 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 1417950 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 24045421 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 32987105 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 22217847 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 2765478 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 2415518 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 7.47e-09 | 3 | 69 | 3 | 22890016 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 9408084 | ||
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 10490589 | ||
| Pubmed | Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice. | 2.99e-08 | 4 | 69 | 3 | 1970547 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 7565685 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GTPBP4 SMARCA5 WAPL POLA1 NVL TAF2 DOT1L NOP2 ZMYM3 RAI1 MPG | 3.10e-08 | 608 | 69 | 11 | 36089195 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 3.11e-08 | 349 | 69 | 9 | 25665578 | |
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 7668294 | ||
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 8587134 | ||
| Pubmed | URB1 WAPL HYOU1 MAP6 PRAMEF15 ARID5B SPIRE1 RBM28 DOT1L BAIAP3 VPS13B PRAMEF11 RAD17 | 1.87e-07 | 1084 | 69 | 13 | 11544199 | |
| Pubmed | 2.60e-07 | 7 | 69 | 3 | 14630516 | ||
| Pubmed | 2.60e-07 | 7 | 69 | 3 | 9630227 | ||
| Pubmed | 4.83e-07 | 483 | 69 | 9 | 36912080 | ||
| Pubmed | 6.22e-07 | 9 | 69 | 3 | 37838304 | ||
| Pubmed | 1.03e-06 | 529 | 69 | 9 | 14621295 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 URB1 SMARCA5 WAPL UTP18 POLA1 TAF2 RBM28 NOP2 BAG6 ZMYM3 AHNAK2 MPG | 2.24e-06 | 1353 | 69 | 13 | 29467282 |
| Pubmed | 3.34e-06 | 15 | 69 | 3 | 29968852 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12325023 | ||
| Pubmed | Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. | 3.88e-06 | 2 | 69 | 2 | 22696418 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30876690 | ||
| Pubmed | Robo signaling regulates the production of cranial neural crest cells. | 3.88e-06 | 2 | 69 | 2 | 28987541 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21395539 | ||
| Pubmed | Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions. | 3.88e-06 | 2 | 69 | 2 | 12162851 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 1302041 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8395817 | ||
| Pubmed | Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice. | 3.88e-06 | 2 | 69 | 2 | 25804444 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 1520280 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23917075 | ||
| Pubmed | Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5. | 3.88e-06 | 2 | 69 | 2 | 30222954 | |
| Pubmed | CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele. | 3.88e-06 | 2 | 69 | 2 | 16636685 | |
| Pubmed | Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver. | 3.88e-06 | 2 | 69 | 2 | 7543189 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27902773 | ||
| Pubmed | Characterization and regulation of sex-specific mouse steroid hydroxylase genes. | 3.88e-06 | 2 | 69 | 2 | 2372744 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31597096 | ||
| Pubmed | The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. | 3.88e-06 | 2 | 69 | 2 | 2322567 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21473878 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 7581481 | ||
| Pubmed | Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ. | 3.88e-06 | 2 | 69 | 2 | 30154104 | |
| Pubmed | Expression of CYP2A genes in human liver and extrahepatic tissues. | 3.88e-06 | 2 | 69 | 2 | 10353262 | |
| Pubmed | Expression and alternative splicing of the cytochrome P-450 CYP2A7. | 3.88e-06 | 2 | 69 | 2 | 7864805 | |
| Pubmed | Robo1 and Robo2 are homophilic binding molecules that promote axonal growth. | 3.88e-06 | 2 | 69 | 2 | 12504588 | |
| Pubmed | Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver. | 3.88e-06 | 2 | 69 | 2 | 28298240 | |
| Pubmed | Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice. | 3.88e-06 | 2 | 69 | 2 | 6309775 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30022126 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21418183 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 22262919 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 25635819 | ||
| Pubmed | Robo1/2 regulate follicle atresia through manipulating granulosa cell apoptosis in mice. | 3.88e-06 | 2 | 69 | 2 | 25988316 | |
| Pubmed | Genetic variation between mice in their metabolism of coumarin and its derivatives. | 3.88e-06 | 2 | 69 | 2 | 566237 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19923441 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12499123 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26608094 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 9458045 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8611142 | ||
| Pubmed | Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver. | 3.88e-06 | 2 | 69 | 2 | 22497566 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 665441 | ||
| Pubmed | Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene. | 3.88e-06 | 2 | 69 | 2 | 24104196 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24247621 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 35584116 | ||
| Pubmed | The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. | 3.88e-06 | 2 | 69 | 2 | 26363552 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 2712571 | ||
| Pubmed | 4.41e-06 | 332 | 69 | 7 | 25693804 | ||
| Pubmed | 4.98e-06 | 17 | 69 | 3 | 27197076 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.34e-06 | 351 | 69 | 7 | 38297188 | |
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 8.32e-06 | 20 | 69 | 3 | 9890157 | |
| Pubmed | Presenilin-dependent receptor processing is required for axon guidance. | 9.69e-06 | 21 | 69 | 3 | 21215373 | |
| Pubmed | 1.10e-05 | 146 | 69 | 5 | 21589869 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 15768400 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18602936 | ||
| Pubmed | Rab35 protein regulates evoked exocytosis of endothelial Weibel-Palade bodies. | 1.16e-05 | 3 | 69 | 2 | 28566286 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18068688 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 11960914 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 3219345 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 14678835 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 14689480 | ||
| Pubmed | Zfp30, a KRAB domain containing zinc finger protein gene, maps to mouse chromosome 7. | 1.16e-05 | 3 | 69 | 2 | 7849402 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 26745454 | ||
| Pubmed | Slit2-Robo Signaling Promotes Glomerular Vascularization and Nephron Development. | 1.16e-05 | 3 | 69 | 2 | 34341180 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20840855 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18272390 | ||
| Pubmed | Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway. | 1.16e-05 | 3 | 69 | 2 | 22552773 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 22373577 | ||
| Pubmed | Robo1 and Robo2 have distinct roles in pioneer longitudinal axon guidance. | 1.16e-05 | 3 | 69 | 2 | 21820427 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 11106424 | ||
| Interaction | CYP2A7 interactions | 3.67e-08 | 3 | 68 | 3 | int:CYP2A7 | |
| Interaction | MNDA interactions | 3.30e-06 | 188 | 68 | 7 | int:MNDA | |
| Interaction | POLR1G interactions | 5.32e-06 | 489 | 68 | 10 | int:POLR1G | |
| Interaction | ZNF48 interactions | 1.11e-05 | 149 | 68 | 6 | int:ZNF48 | |
| Interaction | MAGEB2 interactions | 2.23e-05 | 349 | 68 | 8 | int:MAGEB2 | |
| Interaction | PWP2 interactions | 2.50e-05 | 172 | 68 | 6 | int:PWP2 | |
| Interaction | RRP8 interactions | 2.65e-05 | 259 | 68 | 7 | int:RRP8 | |
| Interaction | NPM3 interactions | 2.86e-05 | 262 | 68 | 7 | int:NPM3 | |
| Interaction | SIRT7 interactions | GTPBP4 URB1 UTP18 HYOU1 POLA1 NVL MAK16 RBM28 NOP2 ZMYM3 RAI1 | 3.63e-05 | 744 | 68 | 11 | int:SIRT7 |
| Interaction | SRPK3 interactions | 4.37e-05 | 190 | 68 | 6 | int:SRPK3 | |
| Interaction | TEK interactions | 5.11e-05 | 119 | 68 | 5 | int:TEK | |
| Interaction | RBM34 interactions | 5.44e-05 | 290 | 68 | 7 | int:RBM34 | |
| Interaction | MST1R interactions | 5.82e-05 | 200 | 68 | 6 | int:MST1R | |
| Interaction | DNAJC9 interactions | 6.19e-05 | 296 | 68 | 7 | int:DNAJC9 | |
| Interaction | NOP2 interactions | 7.72e-05 | 416 | 68 | 8 | int:NOP2 | |
| Interaction | MACROH2A2 interactions | 7.82e-05 | 211 | 68 | 6 | int:MACROH2A2 | |
| Interaction | EBNA1BP2 interactions | 1.09e-04 | 324 | 68 | 7 | int:EBNA1BP2 | |
| Interaction | RPP30 interactions | 1.14e-04 | 141 | 68 | 5 | int:RPP30 | |
| Interaction | WDFY4 interactions | 1.14e-04 | 141 | 68 | 5 | int:WDFY4 | |
| Interaction | ZNF330 interactions | 1.25e-04 | 446 | 68 | 8 | int:ZNF330 | |
| Interaction | ZBTB47 interactions | 1.26e-04 | 144 | 68 | 5 | int:ZBTB47 | |
| Interaction | GPATCH4 interactions | 1.32e-04 | 232 | 68 | 6 | int:GPATCH4 | |
| Interaction | IFI16 interactions | 1.33e-04 | 714 | 68 | 10 | int:IFI16 | |
| Interaction | RNF2 interactions | GTPBP4 SMARCA5 SOWAHA UTP18 HYOU1 GATA3 FBRSL1 AUTS2 RBM28 NOP2 ZMYM3 | 1.41e-04 | 866 | 68 | 11 | int:RNF2 |
| Interaction | RPL3 interactions | 1.45e-04 | 722 | 68 | 10 | int:RPL3 | |
| Interaction | CYP2A13 interactions | 1.67e-04 | 6 | 68 | 2 | int:CYP2A13 | |
| Interaction | NOL12 interactions | 1.68e-04 | 153 | 68 | 5 | int:NOL12 | |
| Interaction | USP36 interactions | 1.76e-04 | 599 | 68 | 9 | int:USP36 | |
| Interaction | MAK16 interactions | 2.19e-04 | 162 | 68 | 5 | int:MAK16 | |
| Interaction | FGFBP1 interactions | 2.29e-04 | 257 | 68 | 6 | int:FGFBP1 | |
| Interaction | AATF interactions | 2.71e-04 | 376 | 68 | 7 | int:AATF | |
| Interaction | CENPA interactions | 2.76e-04 | 377 | 68 | 7 | int:CENPA | |
| Interaction | SRSF6 interactions | 2.83e-04 | 503 | 68 | 8 | int:SRSF6 | |
| Interaction | RPL18 interactions | 3.19e-04 | 512 | 68 | 8 | int:RPL18 | |
| Interaction | FLT1 interactions | 3.47e-04 | 179 | 68 | 5 | int:FLT1 | |
| Interaction | ZNF467 interactions | 3.47e-04 | 179 | 68 | 5 | int:ZNF467 | |
| Interaction | DOT1L interactions | 3.55e-04 | 807 | 68 | 10 | int:DOT1L | |
| Interaction | CEBPZ interactions | 3.70e-04 | 281 | 68 | 6 | int:CEBPZ | |
| Interaction | CYP2A6 interactions | 3.98e-04 | 9 | 68 | 2 | int:CYP2A6 | |
| Interaction | UTP23 interactions | 4.66e-04 | 191 | 68 | 5 | int:UTP23 | |
| Interaction | FGF8 interactions | 4.88e-04 | 108 | 68 | 4 | int:FGF8 | |
| Interaction | PPAN interactions | 4.89e-04 | 193 | 68 | 5 | int:PPAN | |
| Interaction | RSL24D1 interactions | 5.23e-04 | 110 | 68 | 4 | int:RSL24D1 | |
| Interaction | SURF6 interactions | 5.73e-04 | 426 | 68 | 7 | int:SURF6 | |
| Interaction | MRTO4 interactions | 5.75e-04 | 200 | 68 | 5 | int:MRTO4 | |
| Interaction | SLIT3 interactions | 6.05e-04 | 11 | 68 | 2 | int:SLIT3 | |
| Interaction | RPL26L1 interactions | 6.14e-04 | 431 | 68 | 7 | int:RPL26L1 | |
| Interaction | NIFK interactions | 6.14e-04 | 431 | 68 | 7 | int:NIFK | |
| Interaction | MEN1 interactions | GTPBP4 URB1 SMARCA5 WAPL POLA1 GATA3 NVL RBM28 DOT1L NOP2 ZMYM3 | 6.16e-04 | 1029 | 68 | 11 | int:MEN1 |
| Interaction | NOP56 interactions | 6.48e-04 | 570 | 68 | 8 | int:NOP56 | |
| Interaction | MAGEA9 interactions | 6.87e-04 | 208 | 68 | 5 | int:MAGEA9 | |
| Interaction | H2BC8 interactions | 6.94e-04 | 576 | 68 | 8 | int:H2BC8 | |
| Interaction | RBM4 interactions | 7.20e-04 | 319 | 68 | 6 | int:RBM4 | |
| Cytoband | 1p36.21 | 2.60e-06 | 63 | 69 | 4 | 1p36.21 | |
| Cytoband | 8q22.2 | 5.52e-04 | 23 | 69 | 2 | 8q22.2 | |
| Cytoband | 19q13.2 | 1.97e-03 | 164 | 69 | 3 | 19q13.2 | |
| GeneFamily | PRAME family | 4.10e-07 | 24 | 47 | 4 | 686 | |
| GeneFamily | DNA polymerases | 2.81e-05 | 23 | 47 | 3 | 535 | |
| GeneFamily | Cytochrome P450 family 2 | 1.02e-04 | 35 | 47 | 3 | 1001 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 3.14e-06 | 465 | 68 | 9 | M39066 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MAP6 GPR158 UGCG GATA3 AUTS2 ROBO1 ROBO2 KIF3C TMEM132B RYR2 RAI1 AHNAK2 SLC12A5 | 4.54e-06 | 1106 | 68 | 13 | M39071 |
| Coexpression | WENG_POR_DOSAGE | 6.45e-05 | 30 | 68 | 3 | MM1199 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 6.81e-05 | 267 | 68 | 6 | MM984 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 6.85e-05 | 856 | 68 | 10 | M4500 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_UP | 7.88e-05 | 169 | 68 | 5 | M12892 | |
| Coexpression | LEE_BMP2_TARGETS_DN | 1.08e-04 | 904 | 68 | 10 | M2325 | |
| Coexpression | LEE_BMP2_TARGETS_DN | 1.26e-04 | 922 | 68 | 10 | MM1068 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 1.66e-04 | 198 | 68 | 5 | M8036 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 1.70e-04 | 199 | 68 | 5 | M5486 | |
| Coexpression | GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 1.70e-04 | 199 | 68 | 5 | M6926 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 1.74e-04 | 200 | 68 | 5 | M8032 | |
| Coexpression | GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP | 1.74e-04 | 200 | 68 | 5 | M9542 | |
| Coexpression | GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN | 1.74e-04 | 200 | 68 | 5 | M4410 | |
| Coexpression | HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP | 1.78e-04 | 42 | 68 | 3 | M41180 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 1.96e-04 | 463 | 68 | 7 | MM1011 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.04e-04 | 466 | 68 | 7 | M13522 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-06 | 167 | 69 | 5 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-06 | 167 | 69 | 5 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-06 | 167 | 69 | 5 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-06 | 168 | 69 | 5 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-06 | 168 | 69 | 5 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 188 | 69 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 188 | 69 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 198 | 69 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 157 | 69 | 4 | b337937a88f62030114a28d70a63168417672767 | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 157 | 69 | 4 | e6846ffd1bb18bf0469bc6d49ab6cf3533d9cde6 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 158 | 69 | 4 | 9f0987eaf1766aadb5714b68df7a5d310ea5a57a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 159 | 69 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 159 | 69 | 4 | 796e63f6052189106359a4e01eae3e466bf1d593 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 159 | 69 | 4 | 94bc6ab248a8f02ccbc0facd24e0c7e9fda687d2 | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 161 | 69 | 4 | cd4a736d0cec31477c6e8d3b07a04ede1559854b | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 161 | 69 | 4 | 28930ba576625b98cc15993d1499e9dc5edbb5a9 | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 162 | 69 | 4 | ccba6d8d644fe56060ad388ec3a062b7e3b9f086 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 162 | 69 | 4 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 163 | 69 | 4 | e58863a462cc504bced627f004a47890ee2307ce | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 164 | 69 | 4 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 164 | 69 | 4 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 165 | 69 | 4 | 8741df8066a44c841752a99ad306d26ea68f5344 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 166 | 69 | 4 | 325ece9d7dad2b92eeb4defa109853660ac133ca | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 166 | 69 | 4 | be45610f2fe606c328f5688189be40df5e678557 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 167 | 69 | 4 | 895844a45721988788d01120eb880603ba3ca139 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 168 | 69 | 4 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.34e-04 | 168 | 69 | 4 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-04 | 168 | 69 | 4 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 170 | 69 | 4 | aff226a84e397ab58204325aa9d8b396a881986e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 170 | 69 | 4 | 6af16e6f276aec6389ece99505ba13c7edc4c4fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 172 | 69 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-04 | 172 | 69 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 172 | 69 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-04 | 173 | 69 | 4 | 15a77f6aac968b7a1afea4f60aedbb95b9d0f765 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-04 | 175 | 69 | 4 | 9941c35601134d88d1b3249c81f8b43a8fc61610 | |
| ToppCell | COPD-Lymphoid-ILC_A|COPD / Disease state, Lineage and Cell class | 1.60e-04 | 176 | 69 | 4 | 484452cb38fe4604f0910a068361ed461b5b0c21 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 178 | 69 | 4 | 888add8935ef3aef9b6693c5698e9d1842e66337 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 178 | 69 | 4 | 43eda32af2e5e28a92421612d0a4c21e5427a772 | |
| ToppCell | Healthy_Control-Lymphoid-NK-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.68e-04 | 178 | 69 | 4 | 71e99f143009b2d29cb47b96393b58b514c8cfc6 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 178 | 69 | 4 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 179 | 69 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 179 | 69 | 4 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-04 | 179 | 69 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | mild_COVID-19-NK_CD56bright|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.75e-04 | 180 | 69 | 4 | d8b418edd807a51c0b5f4018b8b478dcc65892a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 180 | 69 | 4 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-04 | 182 | 69 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 182 | 69 | 4 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | Healthy_Control-Lymphoid-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.86e-04 | 183 | 69 | 4 | b41b1f32022c8632a638cf1c5523c9a24176f568 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 183 | 69 | 4 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 185 | 69 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.94e-04 | 185 | 69 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.94e-04 | 185 | 69 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 185 | 69 | 4 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 186 | 69 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 2.06e-04 | 188 | 69 | 4 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 2.06e-04 | 188 | 69 | 4 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-04 | 189 | 69 | 4 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 2.11e-04 | 189 | 69 | 4 | 6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 189 | 69 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.15e-04 | 190 | 69 | 4 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.15e-04 | 190 | 69 | 4 | 9f5f65869dad9a43ac94f81f9a19c72ffe5adc3c | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.19e-04 | 191 | 69 | 4 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 191 | 69 | 4 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-04 | 191 | 69 | 4 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.28e-04 | 193 | 69 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | HSPCs-Ery_prog.|World / Lineage and Cell class | 2.28e-04 | 193 | 69 | 4 | 484c2e0daedc6cb0d50d164add8c1658123a60f9 | |
| ToppCell | normal_Lung-Epithelial_cells-Club|normal_Lung / Location, Cell class and cell subclass | 2.37e-04 | 195 | 69 | 4 | b46544ad5af04f4dbc2643637caa3d2d50d922ae | |
| ToppCell | mild_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 2.37e-04 | 195 | 69 | 4 | 980909246c30471c9f2f97c3b20b6d6d20fe574e | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.37e-04 | 195 | 69 | 4 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 2.42e-04 | 196 | 69 | 4 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-04 | 196 | 69 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.47e-04 | 197 | 69 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.47e-04 | 197 | 69 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.47e-04 | 197 | 69 | 4 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | severe-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.52e-04 | 198 | 69 | 4 | 88649dc642193bda5e8eff3f79c832807d5e200a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 198 | 69 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-Treg|ICU-NoSEP / Disease, condition lineage and cell class | 2.52e-04 | 198 | 69 | 4 | 1ed4dfe5565328cb0f7ef31e6b2f67dfbdf3e2ac | |
| ToppCell | normal_Lung-Epithelial_cells-Club|Epithelial_cells / Location, Cell class and cell subclass | 2.52e-04 | 198 | 69 | 4 | a9d0109ca05eb3e9c588f9677ec471dd5c092a75 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.52e-04 | 198 | 69 | 4 | a3d4b6e4259ded2193d94d2ff6d48cf67214fc35 | |
| ToppCell | mLN-(1)_T_cell-(15)_Treg|mLN / shred on region, Cell_type, and subtype | 2.52e-04 | 198 | 69 | 4 | d4885f9c59b275e4e50dfcfb51c5351bebba1769 | |
| ToppCell | mLN-T_cell-Treg|mLN / Region, Cell class and subclass | 2.52e-04 | 198 | 69 | 4 | 6ce9681d1287632956176239f223e71abb8de44f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 198 | 69 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-B_memory|ICU-NoSEP / Disease, condition lineage and cell class | 2.56e-04 | 199 | 69 | 4 | acd2b87ab0d7d92515cf46ab65b766d6ade818a6 | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 2.56e-04 | 199 | 69 | 4 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 69 | 4 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | fd6b4ff4330db11c03f1eb4e06b43a162326f744 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 69 | 4 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Mild / Disease, condition lineage and cell class | 2.61e-04 | 200 | 69 | 4 | bb21e26a8b7cbceddb1ab5163a223a186d914da4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | 8795920911ee75c09a97cc948c14ad7301b27796 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | 347a510755374c6a66acee326565dfc447993f18 | |
| Drug | 2'-methoxyacetophenone | 2.44e-08 | 3 | 67 | 3 | CID000068481 | |
| Drug | nicotine imine | 8.53e-06 | 2 | 67 | 2 | ctd:C034629 | |
| Drug | propargyl ether | 8.53e-06 | 2 | 67 | 2 | ctd:C531209 | |
| Drug | alpha-nicotyrine | 8.53e-06 | 2 | 67 | 2 | ctd:C008615 | |
| Drug | Hempa | 8.53e-06 | 2 | 67 | 2 | ctd:D006492 | |
| Drug | N-nitrosoguvacoline | 8.53e-06 | 2 | 67 | 2 | ctd:C036676 | |
| Drug | N-nitrosomethylaniline | 8.66e-06 | 14 | 67 | 3 | CID000011957 | |
| Drug | N'-nitrosonornicotine | 1.08e-05 | 15 | 67 | 3 | ctd:C008655 | |
| Drug | 2-deoxyxanthosine | 1.61e-05 | 17 | 67 | 3 | CID000065372 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.65e-05 | 183 | 67 | 6 | 7498_DN | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; HL60; HT_HG-U133A | 2.36e-05 | 195 | 67 | 6 | 2386_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA | 2.43e-05 | 196 | 67 | 6 | 1078_UP | |
| Drug | petasiphenol | 3.60e-05 | 22 | 67 | 3 | CID006438779 | |
| Drug | NSC35549 | 3.60e-05 | 22 | 67 | 3 | CID000411697 | |
| Drug | NMPA | 5.10e-05 | 4 | 67 | 2 | CID000132101 | |
| Drug | N'-nitrosoanatabine | 5.10e-05 | 4 | 67 | 2 | ctd:C032978 | |
| Drug | pseudoisocytidine | 5.10e-05 | 4 | 67 | 2 | CID000124345 | |
| Drug | aminoglutethimide | 5.25e-05 | 137 | 67 | 5 | CID000002145 | |
| Drug | 1,N6-ethenodeoxyadenosine | 5.35e-05 | 25 | 67 | 3 | CID000105116 | |
| Drug | 1,2-dibromoethane | 5.74e-05 | 71 | 67 | 4 | CID000007839 | |
| Drug | C14845 | 6.77e-05 | 27 | 67 | 3 | CID011954064 | |
| Drug | BP-9,10-oxide | 6.77e-05 | 27 | 67 | 3 | CID000037456 | |
| Drug | Brn 4136738 | 6.77e-05 | 27 | 67 | 3 | CID000050331 | |
| Drug | 7-hydroxycoumarin | 7.11e-05 | 75 | 67 | 4 | CID005281426 | |
| Drug | 9-OH-BaP-4,5-oxide | 7.57e-05 | 28 | 67 | 3 | CID000115064 | |
| Drug | 5-nitro-1-naphthonitrile | 7.57e-05 | 28 | 67 | 3 | CID000031744 | |
| Drug | Menthol | 7.57e-05 | 28 | 67 | 3 | ctd:D008610 | |
| Drug | tetrahydropalmatine | 8.33e-05 | 151 | 67 | 5 | ctd:C014215 | |
| Drug | trans-3'-hydroxycotinine | 8.43e-05 | 29 | 67 | 3 | CID000000414 | |
| Drug | 2-iodoethanol | 8.48e-05 | 5 | 67 | 2 | CID000012225 | |
| Drug | N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide | 8.48e-05 | 5 | 67 | 2 | ctd:C062567 | |
| Drug | benzyl selenocyanate | 8.48e-05 | 5 | 67 | 2 | ctd:C054108 | |
| Drug | hainanensine | 8.48e-05 | 5 | 67 | 2 | CID000127616 | |
| Drug | 11-H-14,15-EETA | 9.34e-05 | 30 | 67 | 3 | CID011954058 | |
| Drug | 19-hydroxytestosterone | 9.34e-05 | 30 | 67 | 3 | CID000150968 | |
| Drug | BP-7,8-oxide | 1.14e-04 | 32 | 67 | 3 | CID000037455 | |
| Drug | paraoxon | 1.23e-04 | 164 | 67 | 5 | CID000009395 | |
| Drug | acenaphthene-1-ol | 1.27e-04 | 6 | 67 | 2 | ctd:C023723 | |
| Drug | AC1L196J | 1.27e-04 | 6 | 67 | 2 | CID000000415 | |
| Drug | menthofuran | 1.27e-04 | 6 | 67 | 2 | ctd:C054487 | |
| Drug | N'-nitrosoanabasine | 1.27e-04 | 6 | 67 | 2 | ctd:C010257 | |
| Drug | AC1L1HMM | 1.33e-04 | 516 | 67 | 8 | CID000004196 | |
| Drug | 12(13)-EpOME | 1.37e-04 | 34 | 67 | 3 | CID000001416 | |
| Drug | TCEO | 1.37e-04 | 34 | 67 | 3 | CID000028167 | |
| Drug | AC1O5XSP | 1.37e-04 | 34 | 67 | 3 | CID006442739 | |
| Drug | felodipine | 1.41e-04 | 169 | 67 | 5 | CID000003333 | |
| Drug | AC1L1CJI | 1.49e-04 | 35 | 67 | 3 | CID000001929 | |
| Drug | 15-H-11,12-EETA | 1.62e-04 | 36 | 67 | 3 | CID011954042 | |
| Drug | AC1L3NGJ | 1.62e-04 | 36 | 67 | 3 | CID000092121 | |
| Drug | hexamethylphosphoramide | 1.62e-04 | 36 | 67 | 3 | CID000012679 | |
| Drug | (3S,4R,5R)-5-methylolpiperidine-2,3,4-triol | 1.76e-04 | 37 | 67 | 3 | CID010197840 | |
| Drug | miglustat | 1.77e-04 | 7 | 67 | 2 | ctd:C059896 | |
| Drug | acenaphthene | 1.77e-04 | 7 | 67 | 2 | ctd:C042552 | |
| Drug | metyrapone | 1.85e-04 | 179 | 67 | 5 | CID000004174 | |
| Drug | 11,14,15-THET | 2.06e-04 | 39 | 67 | 3 | CID006439531 | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 2.16e-04 | 185 | 67 | 5 | 1114_DN | |
| Drug | Gangliosides | 2.36e-04 | 8 | 67 | 2 | ctd:D005732 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 2.58e-04 | 42 | 67 | 3 | CID006439610 | |
| Drug | ethyl iodoacetate | 2.58e-04 | 42 | 67 | 3 | CID000012183 | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 2389_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 2326_DN | |
| Drug | polybrominated biphenyl | 2.96e-04 | 44 | 67 | 3 | CID000042948 | |
| Drug | N-nitrosoguvacoline | 3.03e-04 | 9 | 67 | 2 | CID000062103 | |
| Drug | 3-(methylnitrosamino)propionaldehyde | 3.03e-04 | 9 | 67 | 2 | CID000098533 | |
| Drug | acenaphthylene | 3.03e-04 | 9 | 67 | 2 | ctd:C042553 | |
| Drug | naphthalene-1,2-dihydrodiol | 3.16e-04 | 45 | 67 | 3 | CID000000362 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 9.06e-05 | 7 | 62 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | Liver Diseases, Parasitic | 1.55e-04 | 9 | 62 | 2 | C0023897 | |
| Disease | nicotine metabolite ratio | 2.83e-04 | 12 | 62 | 2 | EFO_0007794 | |
| Disease | forced expiratory volume, response to bronchodilator | 3.43e-04 | 445 | 62 | 6 | EFO_0004314, GO_0097366 | |
| Disease | acute lymphoblastic leukemia | 3.68e-04 | 66 | 62 | 3 | EFO_0000220 | |
| Disease | B-cell acute lymphoblastic leukemia | 4.48e-04 | 15 | 62 | 2 | EFO_0000094 | |
| Disease | susceptibility to childhood ear infection measurement | 4.67e-04 | 171 | 62 | 4 | EFO_0007904 | |
| Disease | visceral adipose tissue measurement | 5.17e-04 | 481 | 62 | 6 | EFO_0004765 | |
| Disease | emphysema pattern measurement | 7.26e-04 | 19 | 62 | 2 | EFO_0005850 | |
| Disease | caffeine metabolite measurement | 7.26e-04 | 19 | 62 | 2 | EFO_0007872 | |
| Disease | smoking behavior | 7.55e-04 | 341 | 62 | 5 | EFO_0004318 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 8.89e-04 | 21 | 62 | 2 | C1292769 | |
| Disease | Carcinoma, Granular Cell | 1.89e-03 | 116 | 62 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.89e-03 | 116 | 62 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.89e-03 | 116 | 62 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.89e-03 | 116 | 62 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.89e-03 | 116 | 62 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.89e-03 | 116 | 62 | 3 | C0001418 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGARKVPLQPSKQMK | 151 | Q9HCM7 | |
| GKNRQPKFEDRAKMP | 336 | P11509 | |
| MPAKRRKTMQGEGPQ | 1046 | P46379 | |
| MRLMLKKGEGRQGLP | 91 | O94812 | |
| RVRQPGMKGNPKKPN | 536 | Q86TB3 | |
| GMKGNPKKPNANLRE | 541 | Q86TB3 | |
| KNTQGPRMPRTAKKV | 501 | Q9BZE4 | |
| RGRPKKMNTANPERK | 411 | Q8TEK3 | |
| MGIKKPQPGQRQEKE | 486 | Q15057 | |
| MDPRGILKAFPKRQK | 1 | Q9UGP5 | |
| QGAMKTKVLPPRKGR | 1311 | Q7Z5J4 | |
| LEVNIPRKPDGKMRG | 141 | Q9NW13 | |
| KREKMRAKQNPPGPA | 26 | Q96IZ0 | |
| KGENNLRPRKKGMSL | 346 | O75943 | |
| MKPRPAGFVDNKLKQ | 1 | O15381 | |
| KIIKQPQRVGAGPMK | 521 | P19113 | |
| GKRPKKGMATAKQRL | 911 | Q6ZMT4 | |
| LKGQGPMVQEPLKKQ | 471 | Q96JE9 | |
| HKGKMPLRGPLQRKR | 266 | Q9BXY0 | |
| MPNPKNSKGGRKNKR | 1 | Q9UBI9 | |
| EPRKPQKSGIMKQQR | 966 | Q5T848 | |
| KAQLEKRGMLGKRPR | 391 | O14782 | |
| KKMPKALRQLKPGQN | 166 | Q8WXX7 | |
| KRNKKPVQDCPRMRG | 131 | P0DUQ1 | |
| KIGRLKRSNMPKLGG | 661 | P09884 | |
| PDVGQPRRKTAKMLK | 266 | Q9Y251 | |
| EKMLRDQQGPSKKPA | 1211 | Q6ZV29 | |
| HKMNGQNRPLIKPKR | 291 | P23771 | |
| PEGEKKQKPARKRRM | 681 | Q9Y4L1 | |
| GKNRQPKFEDRAKMP | 336 | Q16696 | |
| GRDPEMGGKPQRRKN | 91 | P20963 | |
| MGGKPQRRKNPQEGL | 96 | P20963 | |
| GKNRQPKFEDRTKMP | 336 | P20853 | |
| LKLPPNREMKNQGSK | 2141 | O75417 | |
| GEDDKMPPLRKKQRG | 1731 | Q5VT06 | |
| PKQFCRRMGQKKQRP | 11 | P29372 | |
| ILPKNKGRMQNKKPG | 836 | Q5U5Z8 | |
| GKKVGINPKINNLMP | 116 | Q16739 | |
| GKRPKEGLLQMKLPE | 1886 | Q92736 | |
| NNEGGKKKPVQAPRM | 106 | Q9H2X9 | |
| LDRRTGAKPKRKPGM | 11 | Q9Y5J1 | |
| NEPMNSSGPKRKRVK | 1011 | Q14DG7 | |
| RKGKNEVKPVQMNAP | 86 | Q8NE09 | |
| MNRKKGDKGFESPRP | 11 | Q6P1X5 | |
| WNKKRMRGPGKDPTR | 186 | Q8NET5 | |
| LKLMKQRRKPPGFLA | 311 | Q9UL41 | |
| KRNKKPVQDCPRMRG | 131 | A6NGN4 | |
| MGRKLDPTKEKRGPG | 1 | P46087 | |
| DKNKPVMPARAKGPR | 2016 | O60287 | |
| MPKVDRKGPQIDIKG | 3236 | Q8IVF2 | |
| RGNPGIMSPLAKKKL | 681 | Q14865 | |
| RKMWRPGEKKEPQGV | 6 | O75762 | |
| AAQKRKGKEPGMALP | 6 | Q96N58 | |
| MAPRKKTKIRGGLPA | 511 | Q2M3V2 | |
| EEIPRMHPGRNGKKQ | 186 | P49763 | |
| MHPGRNGKKQQRKPL | 191 | P49763 | |
| RKVMVNGDIPPRLKK | 321 | Q08AE8 | |
| KRNKKPVQDCPRMRG | 131 | P0DUQ2 | |
| MAKLGQKRPNFKPDI | 41 | Q7Z5K2 | |
| KRNKKPVQDCPRMRG | 131 | O60813 | |
| RPTKKHKGGRMDQQP | 1286 | Q9HCK4 | |
| KKGARTPKVPKQGGM | 1166 | Q9Y6N7 | |
| RAQGRAQMGPKKEPT | 161 | Q5TFG8 | |
| KTQKEKRKSPGQPMR | 1521 | Q7Z7G8 | |
| RQGKPMSQPRDLGKA | 721 | Q63HK3 | |
| AAQKRKGKEPGMALP | 6 | Q8N823 | |
| RGPKPSTQKRKMDGA | 1026 | O60264 | |
| GLVPMNKIPKDNKQR | 1771 | A3KMH1 | |
| RKQMKGRGQLEKPPA | 436 | Q9BXI6 | |
| MSGREGGKKKPLKQP | 1 | Q9Y2S6 | |
| NKLVMRRKGISGKGP | 396 | Q9NQA3 | |
| KGDELRFGPKPMRIK | 1086 | Q14202 |